Ellicott City, MD, United States of America

Edward W Karbon, Jr

This inventor holds 1 USPTO granted patent. Top assignee: Guilford Pharmaceuticals, Inc.. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Edward W Karbon, Jr. Retrieved from https://idiyas.com/inventor/edward-w-karbon-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Edward W Karbon, Jr: Innovator in Neurotransmitter Research

Introduction

Edward W Karbon, Jr. is a notable inventor based in Ellicott City, MD (US). He has made significant contributions to the field of neurotransmitter research, particularly through his innovative patent. His work focuses on the development of compounds that serve as antagonists for excitatory amino acid neurotransmitter receptors.

Latest Patents

Karbon holds a patent for .omega.-[2-(phosphonoalkyl)phenyl]-2-aminoalkanoic acids as antagonists. This invention pertains to the preparation of these antagonists and their compositions, which have a general formula that includes various chemical groups. The patent highlights the potential therapeutic applications of these compounds in treating neurological conditions.

Career Highlights

Edward W Karbon, Jr. is associated with Guilford Pharmaceuticals, Inc., where he has contributed to advancing pharmaceutical research and development. His expertise in the field has led to the creation of valuable intellectual property that enhances the understanding of neurotransmitter interactions.

Collaborations

Throughout his career, Karbon has collaborated with esteemed colleagues, including Waclaw J Rzeszotarski and Suzanne R Ellenberger. These partnerships have fostered a collaborative environment that promotes innovation and scientific discovery.

Conclusion

Edward W Karbon, Jr. exemplifies the spirit of innovation in the pharmaceutical industry. His contributions to neurotransmitter research through his patent demonstrate the importance of scientific inquiry and collaboration in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…